06:00 PM EDT, 07/02/2025 (MT Newswires) -- Brett Sandercock, Chief Financial Officer, on July 01, 2025, sold 3,883 shares in ResMed ( RMD ) for $997,892. Following the Form 4 filing with the SEC, Sandercock has control over a total of 84,283 common shares of the company, with 84,283 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/943819/000094381925000025/xslF345X05/form4.xml